Apple Designs New App to Allow Use of iPhones to Recruit and Track Patients in Clinical Study as One Strategy to Become a Player in Healthcare Big Data

Researchers, including pathologists, can use Apple’s ResearchKit app to help collect and share genetic information about cancers and other diseases while building a huge genome database By providing tools to allow users to be more productive in working with healthcare big data, several Silicon Valley giants hope to increase their presence in medical services. The latest company to enter the field is Apple Computers (NASDAQ:AAPL). In March it announced the availability of ResearchKit, an...

University of Illinois Researchers Develop New Way to Assess Freshness and Effectiveness of Whole Blood; Pathologists and Blood Bankers May Be Surprised at the Findings

Some changes in red blood cells that occur within current 42-day use guidelines may not be apparent to the human eye, but offer a new way to measure the amount of oxygen that the cells can carry At the University of Illinois (UI), researchers have developed a new method to assess the freshness and clinical effectiveness of whole blood. As these findings are validated, pathologists and clinical laboratory scientists who manage hospital blood banks may need to establish new guidelines for the...

VA Wants to Collect Clinical Laboratory Blood Specimens from One Million Veterans to Create World’s Largest Medical Database and Gene Repository

Veterans Administration calls it a “genomics game changer” and is now building a treasure trove of data for health researchers, including pathologists Imagine a massive data repository that contains the blood specimens and genetic information of thousands of individuals, along with a detailed medical history for each patient that may reach back as far as 20 years! Such a data repository, long the dream of many pathologists and clinical laboratory scientists, will soon become a reality. That’s...

Magnetic Biomarker Chip Spots Cancer Before It Develops

Up to 400 times more sensitive than existing ELISA-based methods Detecting any of seven cancers in their earliest stages may be feasible through the use of a new biomarker chip that was recently unveiled by scientists from Stanford University’s Center for Magnetic Nanotechnology. To give their biomarker chip increased sensitivity over fluorescent detection methods, the scientists use magnetic technologies to accomplish detection. Reporting in Proceedings of the National Academy of Sciences...

Comparative Effectiveness: It’s Here! It’s Now! And It’s Funded to the Tune of $1.1 Billion!

Effort will identify which clinical procedures actually benefit patients—and are cost-effective “Comparative effectiveness research (CER)” is likely to be one method that healthcare reformers use to establish reimbursement for different medical technologies and treatments. This will apply equally to clinical laboratory testing and pathology professional services as well as other medical procedures. There is a compelling reason why comparative effectiveness is likely to happen on this turn of...